Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The finding means that building larger AI models for protein design, and feeding them more data, will produce predictably ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

Biotech company Colossal Biosciences said it has brought back the dire wolf, an animal that went extinct 10,000 years ago, ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Colossal Biosciences says it used novel gene-editing technology to alter gray wolf DNA to breed the animals. Dire wolves ...

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers ...